Article (Scientific journals)
Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression.
Weras, S; Belayew, Alexandra; Martial, JA
1995In FEBS Letters, 358 (2), p. 158-160
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-001457939401416X-main.pdf
Publisher postprint (267.29 kB)
Request a copy

All documents in ORBi UMONS are protected by a user license.

Send to



Details



Abstract :
[en] In this work we demonstrate that transcription of the human prolactin gene is inhibited by the immunosuppressants FK506 (IC50 = 25 NM), cyclosporin A (IC50 = 190 NM) and rapamycin (IC50 = 25 NM). Whereas the effect of FK506 and cyclosporin A is specific for prolactin gene transcription, rapamycin has a more general effect on transcription and/or translation in pituitary cells. In view of recent work demonstrating the immunoactivating role of prolactin, these results suggest that inhibition of prolactin gene expression in the pituitary may contribute to the mechanism of action of immunosuppressants.
Disciplines :
Biotechnology
Author, co-author :
Weras, S
Belayew, Alexandra 
Martial, JA
Language :
English
Title :
Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression.
Publication date :
23 January 1995
Journal title :
FEBS Letters
ISSN :
0014-5793
eISSN :
1873-3468
Publisher :
Wiley-Blackwell, United States
Volume :
358
Issue :
2
Pages :
158-160
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi UMONS :
since 11 July 2013

Statistics


Number of views
0 (0 by UMONS)
Number of downloads
0 (0 by UMONS)

Bibliography


Similar publications



Contact ORBi UMONS